A Study to Evaluate Solrikitug in Participants With COPD (ZION)

NCT06496620 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

171

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

BIOLOGICAL: Biological: Solrikitug low dose
BIOLOGICAL: Biological: Solrikitug high dose
OTHER: Placebo

Sponsor

Uniquity One (UNI)

Collaborators

[object Object]